Friday, February 1, 2019


An Analysis Of FDA FY2018 Drug GMP Warning Letters

Life Science Leader Magazine-9 hours ago
The term “compounding pharmacy” used here includes outsourcing facilities and is considered a separate category from drug manufacturers based on their ..

Concern Over Glutathione-L-reduced Powder Prompts FDA Warning ...

Pharmacy Times-2 hours ago
The FDA is urging compounders that use glutathione to make sterile injectable drugs to ensure the glutathione powder is appropriate for compounding sterile ...
22 hours ago - In December 2018 the FDA released a new draft guidance addressing the standards outsourcing facilities must follow in their compounding activities. How wil